Healthcare Virtual Assistants Market Size Worth $5.31Bn, Globally, by 2028 at 34.01% CAGR - Exclusive Report by The Insight Partners
17 févr. 2022 08h22 HE
|
The Insight Partners
New York, Feb. 17, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Healthcare Virtual Assistants Market Forecast to 2028 - COVID-19 Impact and Global Analysis By...
Fall Management Market Size Worth $230.10 Mn, Globally, by 2028 at 4.3% CAGR - Exclusive Report by The Insight Partners
17 févr. 2022 05h29 HE
|
The Insight Partners
New York, Feb. 17, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Fall Management Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Sensor...
BioNTech stellt erste modulare mRNA-Produktionsanlage zur Unterstützung einer skalierbaren Impfstoffproduktion in Afrika vor
16 févr. 2022 05h30 HE
|
BioNTech SE
Entwicklung von schlüsselfertigen modularen Produktionsanlagen als Lösung für eine skalierbare Herstellung von mRNA-basierten Impfstoffen; Anlagen werden von BioNTech eingerichtetTreffen der...
BioNTech introduces first modular mRNA manufacturing facility to promote scalable vaccine production in Africa
16 févr. 2022 05h30 HE
|
BioNTech SE
Developing turnkey solution to enable mRNA-based vaccine production in modular and scalable sites installed by BioNTech Presidents of Ghana, Rwanda, Senegal, the Director-General of the World Health...
BioNTech nimmt an Spitzentreffen mit Partnern in Marburg teil und hält Pressekonferenz zu Plänen für nachhaltige Impfstoffherstellung in Afrika
15 févr. 2022 09h40 HE
|
BioNTech SE
MAINZ, Deutschland, 15. Februar 2022 – BioNTech SE (Nasdaq: BNTX, „BioNTech“ oder „das Unternehmen“) wird Projektpartner, darunter auch offizielle Regierungsvertreter und –vertreterinnen, bei einem...
BioNTech to Join High-level Meeting with Partners in Marburg and to Hold Press Conference to Provide an Update on Sustainable Vaccine Manufacturing in Africa
15 févr. 2022 09h40 HE
|
BioNTech SE
MAINZ, Germany, February 15, 2022 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will welcome project partners, among them official representatives, in Marburg to conduct a high-level...
$3.06Bn by 2027, Pharmaceutical Continuous Manufacturing Market Size, 9.8% CAGR Lead by Integrated Systems - Exclusive Research Report by The Insight Partners
09 févr. 2022 08h47 HE
|
The Insight Partners
New York, Feb. 09, 2022 (GLOBE NEWSWIRE) -- According to our new research study on “Pharmaceutical Continuous Manufacturing Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product...
DEPRESSION PATENT FOR OROTATE APPROVED & GRANTED BY US PATENT OFFICE
11 oct. 2021 10h40 HE
|
Medlab Clinical Ltd
SYDNEY, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Medlab Clinical LTD (ASX:MDC) is pleased to announce the Orotate patent, specifically to addressing depression in United States of America has been granted....
Celsion and Hainan Poly Pharm Sign Agreement to Manufacture Celsion’s DNA-based Vaccine
17 sept. 2021 09h00 HE
|
Celsion CORP
Expands GEN-1 Program Collaboration to Add Clinical and Commercial Batches of Investigational Vaccine LAWRENCEVILLE, N.J. and HAINAN, China, Sept. 17, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation...
Dyadic Announces Technology Transfer and Licensing Agreement With South Africa’s Rubic Consortium Aiming to Develop and Commercialize Vaccines for Distribution Throughout the African Continent
27 juil. 2021 08h20 HE
|
Dyadic International, Inc.
Arrangement includes C1 COVID-19 vaccine technology transfer and licensing agreementProvides potential funding pathway for a C1 manufactured COVID-19 vaccine to progress through Phase II and Phase III...